Stuart Beattie

Stuart Beattie is currently the Gene Therapy Global Regulatory CMC Clinical Lead - Associate Director at Biogen. With a PhD in Biochemistry from Royal Holloway, University of London, they have built a diverse career in gene therapy, including roles at UMass Medical School and uniQure, where they focused on AAV-based therapeutics. Prior experience includes positions at Diamond Pharma Services and GSK, managing regulatory product development for advanced therapy medicinal products. Beattie has contributed to multiple research institutes and has a strong background in both academic and industrial settings.